ReShape Lifesciences Operating Margin 2015-2024 | RSLS
Current and historical operating margin for ReShape Lifesciences (RSLS) over the last 10 years. The current operating profit margin for ReShape Lifesciences as of December 31, 2024 is -89.06%.
| ReShape Lifesciences Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.01B | $-0.01B | -100.00% |
| 2024-09-30 | $0.01B | $-0.01B | -100.00% |
| 2024-06-30 | $0.01B | $-0.01B | -125.00% |
| 2024-03-31 | $0.01B | $-0.01B | -150.00% |
| 2023-12-31 | $0.01B | $-0.02B | -200.00% |
| 2023-09-30 | $0.01B | $-0.03B | -344.44% |
| 2023-06-30 | $0.01B | $-0.04B | -390.00% |
| 2023-03-31 | $0.01B | $-0.04B | -400.00% |
| 2022-12-31 | $0.01B | $-0.05B | -418.18% |
| 2022-09-30 | $0.01B | $-0.07B | -600.00% |
| 2022-06-30 | $0.01B | $-0.07B | -575.00% |
| 2022-03-31 | $0.01B | $-0.06B | -492.31% |
| 2021-12-31 | $0.01B | $-0.06B | -414.29% |
| 2021-09-30 | $0.02B | $-0.02B | -143.75% |
| 2021-06-30 | $0.02B | $-0.01B | -62.50% |
| 2021-03-31 | $0.01B | $-0.01B | -64.29% |
| 2020-12-31 | $0.01B | $-0.01B | -100.00% |
| 2020-09-30 | $0.01B | $-0.02B | -187.50% |
| 2020-06-30 | $0.00B | $-0.02B | -425.00% |
| 2020-03-31 | $0.00B | $-0.02B | -1000.00% |
| 2019-12-31 | $0.00B | $-0.02B | -766.67% |
| 2019-09-30 | $0.00B | $-0.03B | -675.00% |
| 2019-06-30 | $0.01B | $-0.03B | -428.57% |
| 2019-03-31 | $0.01B | $-0.03B | -340.00% |
| 2018-12-31 | $0.01B | $-0.04B | -422.22% |
| 2018-09-30 | $0.01B | $-0.04B | -354.55% |
| 2018-06-30 | $0.01B | $-0.04B | -372.73% |
| 2018-03-31 | $0.01B | $-0.04B | -390.00% |
| 2017-12-31 | $0.01B | $-0.04B | -350.00% |
| 2017-09-30 | $0.01B | $-0.03B | -471.43% |
| 2017-06-30 | $0.01B | $-0.03B | -560.00% |
| 2017-03-31 | $0.00B | $-0.02B | -600.00% |
| 2016-12-31 | $0.00B | $-0.02B | -475.00% |
| 2016-06-30 | $0.00B | $-0.01B | -333.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.005B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $190.127B | 83.28 |
| Thermo Fisher Scientific (TMO) | United States | $153.648B | 18.58 |
| Alcon (ALC) | Switzerland | $47.347B | 31.47 |
| Edwards Lifesciences (EW) | United States | $44.043B | 28.82 |
| IDEXX Laboratories (IDXX) | United States | $38.097B | 43.78 |
| DexCom (DXCM) | United States | $31.969B | 49.41 |
| IQVIA Holdings (IQV) | United States | $25.777B | 14.17 |
| Mettler-Toledo (MTD) | United States | $22.100B | 26.28 |
| STERIS (STE) | Ireland | $21.856B | 24.99 |
| Waters (WAT) | United States | $20.170B | 28.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.308B | 0.00 |
| Hologic (HOLX) | United States | $11.835B | 12.86 |
| Sysmex ADR (SSMXY) | Japan | $11.715B | 0.00 |
| Penumbra (PEN) | United States | $11.306B | 88.74 |
| Globus Medical (GMED) | United States | $9.687B | 22.43 |
| Masimo (MASI) | United States | $8.725B | 32.29 |
| Teleflex (TFX) | United States | $5.328B | 8.79 |
| Glaukos (GKOS) | United States | $4.983B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.125B | 21.61 |
| TransMedics (TMDX) | United States | $3.159B | 92.46 |
| PROCEPT BioRobotics (PRCT) | United States | $2.945B | 0.00 |
| Veracyte (VCYT) | United States | $2.393B | 43.04 |
| LivaNova (LIVN) | United Kingdom | $1.917B | 11.60 |
| Elekta AB (EKTAY) | Sweden | $1.889B | 16.98 |
| Nihon Kohden (NHNKY) | Japan | $1.867B | 10.21 |
| Alphatec Holdings (ATEC) | United States | $1.779B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.420B | 0.00 |
| Artivion (AORT) | United States | $1.171B | 109.68 |
| Pulse Biosciences (PLSE) | United States | $1.113B | 0.00 |
| OPKO Health (OPK) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.991B | 5.27 |
| AxoGen (AXGN) | United States | $0.747B | 0.00 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| IRadimed (IRMD) | United States | $0.649B | 32.92 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 14.01 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.591B | 9.24 |
| RxSight (RXST) | United States | $0.567B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.350B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 6.74 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.94 |
| CVRx (CVRX) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.190B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.60 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.054B | 0.00 |
| Hyperfine (HYPR) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |